BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 26679229)

  • 1. Inhibiting receptor for advanced glycation end product (AGE) and oxidative stress involved in the protective effect mediated by glucagon-like peptide-1 receptor on AGE induced neuronal apoptosis.
    Chen S; Yin L; Xu Z; An FM; Liu AR; Wang Y; Yao WB; Gao XD
    Neurosci Lett; 2016 Jan; 612():193-198. PubMed ID: 26679229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucagon-like peptide-1 regulates mitochondrial biogenesis and tau phosphorylation against advanced glycation end product-induced neuronal insult: Studies in vivo and in vitro.
    An FM; Chen S; Xu Z; Yin L; Wang Y; Liu AR; Yao WB; Gao XD
    Neuroscience; 2015 Aug; 300():75-84. PubMed ID: 25987199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucagon-like peptide-1 attenuates advanced oxidation protein product-mediated damage in islet microvascular endothelial cells partly through the RAGE pathway.
    Zhang Z; Yang L; Lei L; Chen R; Chen H; Zhang H
    Int J Mol Med; 2016 Oct; 38(4):1161-9. PubMed ID: 27574116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucagon-like peptide-1 protects hippocampal neurons against advanced glycation end product-induced tau hyperphosphorylation.
    Chen S; An FM; Yin L; Liu AR; Yin DK; Yao WB; Gao XD
    Neuroscience; 2014 Jan; 256():137-46. PubMed ID: 24183963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucagon-like peptide-1 receptor agonist inhibits asymmetric dimethylarginine generation in the kidney of streptozotocin-induced diabetic rats by blocking advanced glycation end product-induced protein arginine methyltranferase-1 expression.
    Ojima A; Ishibashi Y; Matsui T; Maeda S; Nishino Y; Takeuchi M; Fukami K; Yamagishi S
    Am J Pathol; 2013 Jan; 182(1):132-41. PubMed ID: 23159951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of glucagon-like peptide-1 on advanced glycation endproduct-induced aortic endothelial dysfunction in streptozotocin-induced diabetic rats: possible roles of Rho kinase- and AMP kinase-mediated nuclear factor κB signaling pathways.
    Tang ST; Zhang Q; Tang HQ; Wang CJ; Su H; Zhou Q; Wei W; Zhu HQ; Wang Y
    Endocrine; 2016 Jul; 53(1):107-16. PubMed ID: 26758998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucagon-like peptide-1 inhibits the receptor for advanced glycation endproducts to prevent podocyte apoptosis induced by advanced oxidative protein products.
    Zhang SS; Wu Z; Zhang Z; Xiong ZY; Chen H; Huang QB
    Biochem Biophys Res Commun; 2017 Jan; 482(4):1413-1419. PubMed ID: 27965099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. iRAGE as a novel carboxymethylated peptide that prevents advanced glycation end product-induced apoptosis and endoplasmic reticulum stress in vascular smooth muscle cells.
    Maltais JS; Simard E; Froehlich U; Denault JB; Gendron L; Grandbois M
    Pharmacol Res; 2016 Feb; 104():176-85. PubMed ID: 26707030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RAGE Expression and ROS Generation in Neurons: Differentiation versus Damage.
    Piras S; Furfaro AL; Domenicotti C; Traverso N; Marinari UM; Pronzato MA; Nitti M
    Oxid Med Cell Longev; 2016; 2016():9348651. PubMed ID: 27313835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced oxidation protein products induce chondrocyte apoptosis via receptor for advanced glycation end products-mediated, redox-dependent intrinsic apoptosis pathway.
    Wu Q; Zhong ZM; Zhu SY; Liao CR; Pan Y; Zeng JH; Zheng S; Ding RT; Lin QS; Ye Q; Ye WB; Li W; Chen JT
    Apoptosis; 2016 Jan; 21(1):36-50. PubMed ID: 26520447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The protective effect of Smilax glabra extract on advanced glycation end products-induced endothelial dysfunction in HUVECs via RAGE-ERK1/2-NF-κB pathway.
    Sang HQ; Gu JF; Yuan JR; Zhang MH; Jia XB; Feng L
    J Ethnopharmacol; 2014 Aug; 155(1):785-95. PubMed ID: 24953033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagon-like peptide-1 suppresses advanced glycation end product-induced monocyte chemoattractant protein-1 expression in mesangial cells by reducing advanced glycation end product receptor level.
    Ishibashi Y; Nishino Y; Matsui T; Takeuchi M; Yamagishi S
    Metabolism; 2011 Sep; 60(9):1271-7. PubMed ID: 21388644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The protective effects of dulaglutide against advanced glycation end products (AGEs)-induced degradation of type Ⅱ collagen and aggrecan in human SW1353 chondrocytes.
    Li H; Chen J; Li B; Fang X
    Chem Biol Interact; 2020 May; 322():108968. PubMed ID: 32004530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced oxidation protein products induce apoptosis in podocytes through induction of endoplasmic reticulum stress.
    Rong G; Tang X; Guo T; Duan N; Wang Y; Yang L; Zhang J; Liang X
    J Physiol Biochem; 2015 Sep; 71(3):455-70. PubMed ID: 26197866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A specific RAGE-binding peptide biopanning from phage display random peptide library that ameliorates symptoms in amyloid β peptide-mediated neuronal disorder.
    Cai C; Dai X; Zhu Y; Lian M; Xiao F; Dong F; Zhang Q; Huang Y; Zheng Q
    Appl Microbiol Biotechnol; 2016 Jan; 100(2):825-35. PubMed ID: 26496918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salidroside attenuates beta amyloid-induced cognitive deficits via modulating oxidative stress and inflammatory mediators in rat hippocampus.
    Zhang J; Zhen YF; Pu-Bu-Ci-Ren ; Song LG; Kong WN; Shao TM; Li X; Chai XQ
    Behav Brain Res; 2013 May; 244():70-81. PubMed ID: 23396166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon-like peptide-1 analogue liraglutide ameliorates atherogenesis via inhibiting advanced glycation end product-induced receptor for advanced glycosylation end product expression in apolipoprotein-E deficient mice.
    Li P; Tang Z; Wang L; Feng B
    Mol Med Rep; 2017 Sep; 16(3):3421-3426. PubMed ID: 28713911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mangiferin suppressed advanced glycation end products (AGEs) through NF-κB deactivation and displayed anti-inflammatory effects in streptozotocin and high fat diet-diabetic cardiomyopathy rats.
    Hou J; Zheng D; Fung G; Deng H; Chen L; Liang J; Jiang Y; Hu Y
    Can J Physiol Pharmacol; 2016 Mar; 94(3):332-40. PubMed ID: 26751764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schisandrin B Ameliorates ICV-Infused Amyloid β Induced Oxidative Stress and Neuronal Dysfunction through Inhibiting RAGE/NF-κB/MAPK and Up-Regulating HSP/Beclin Expression.
    Giridharan VV; Thandavarayan RA; Arumugam S; Mizuno M; Nawa H; Suzuki K; Ko KM; Krishnamurthy P; Watanabe K; Konishi T
    PLoS One; 2015; 10(11):e0142483. PubMed ID: 26556721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of glycyrrhizic acid against AGEs-induced endothelial dysfunction through inhibiting RAGE/NF-κB pathway activation in human umbilical vein endothelial cells.
    Feng L; Zhu MM; Zhang MH; Wang RS; Tan XB; Song J; Ding SM; Jia XB; Hu SY
    J Ethnopharmacol; 2013 Jun; 148(1):27-36. PubMed ID: 23528363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.